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The practical use of genome sequencing
data in the management of a feline colony
pedigree
Fabiana H. G. Farias1*, Chad Tomlinson1, Jeffrey Labuda2, Gerardo Perez-Camargo2, Rondo Middleton2
and Wesley C. Warren1*
Abstract
Background: A higher prevalence of inherited disorders among companion animals are often rooted in their historical
restricted artificial selection for a variety of observed phenotypes that eventually decreased genetic diversity. Cats have
been afflicted with many inherited diseases due to domestication and intense breed selection. Advances in sequencing
technology have generated a more comprehensive way to access genetic information from an individual, allowing
identification of putative disease-causing variants and in practice a means to avoid their spread and thus better pedigree
management. We examine variants in three domestic shorthair cats and then calculated overall genetic diversity to
extrapolate the benefits of this data for breeding programs within a feline colony.
Results: We generated whole genome sequence (WGS) data for three related cats that belong to a large feline pedigree
colony. Genome-wide coverage ranged from 27-32X, from which we identified 18 million variants in total. Previously
known disease-causing variants were screened in our cats, but none carry any of these known disease alleles. Loss of
function (LoF) variants, that are in genes associated with a detrimental phenotype in human or mice were chosen for
further evaluation on the comparative impact inferred. A set of LoF variants were observed in four genes, each with
predicted detrimental phenotypes as a result. However, none of our cats displayed the expected disease phenotypes.
Inbreeding coefficients and runs of homozygosity were also evaluated as a measure of genetic diversity. We find low
inbreeding coefficients and total runs of homozygosity, thus suggesting pedigree management of genetic relatedness is
acceptable.
Conclusions: The use of WGS of a small sampling among a large feline colony has enabled us to identify possible
disease-causing variants, their genotype state and measure pedigree management of genetic diversity. We contend a
limited but strategic sampling of feline colony individuals using WGS can inform veterinarians of future health anomalies
and guide breeding practices to ensure healthy genetic diversity.
Keywords: Whole-genome sequencing, Cats, Loss of function variants
Background
The use of pedigreed colonies remains a powerful re-
source to study many phenotypes of interest in great de-
tail, yet among companion animals, specifically dogs and
cats, large well-maintained pedigrees for such use are
rare and not readily available. Given this rarity, their op-
timal use in the understanding of health and behavioral
well-being is of crucial importance. Disease surveillance
is a critical component of comprehensive veterinary care
programs to detect and prevent the spread of disease
within animal colonies, thereby enhancing the quality of
life of these animals. Veterinary health checks routinely
include the collection of samples that can provide a
means to detect existing or future health problems and
thus provide appropriate care directly to benefit the ani-
mal. With the advances underway in the collection of
electronic medical records for companion animal pa-
tients, mimicking efforts in human clinical practice, the
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ability to return to banked samples for basic disease re-
search or clinical testing to provide optimal care has vet-
erinarians excited about these health management
opportunities. Data collection such as a whole genome
or targeted sequencing, immunoassays, metabolite pro-
filing, fixed genotyping and others, collectively or in iso-
lation can drive discovery of the sources of trait diversity
linked to genetic variation.
Information provided by genetic data can aid breeding
programs by reducing introduction and propagation of
health problems in a pedigree. There are many diseases
in animals that have been associated with gene variants,
for some of those variants, there are commercial genetic
tests available [1]. The ability to select individuals based
on genetic information circumvents the issue of produ-
cing progeny with health issues that can be unfavorable
for these animals. Especially in occasions where disease
symptoms appear later than breeding age, without gen-
etic information, those animals will be included in the
breeding program resulting in dissemination of undesir-
able traits. Polycystic kidney disease (PKD) in Persian
cats is an example of a disease in which symptoms ap-
pear after breeding age [2]. Lyons et al. [3] have identi-
fied the causative mutation for PKD in the gene PKD1,
and a commercial genetic test is available enabling Per-
sian cat breeders to make mating decisions based on
genetic information.
WGS although still costly for companion animal veter-
inary practice is the most comprehensive method for de-
tection of an individual’s genetic variation. WGS has
enabled enormous progress in understanding disease in
human and animals. Moreover, it allows extensive evalu-
ation of genetic diversity which is essential for the main-
tenance of a healthy pedigree. However, the interpretation
of the enormous amount of genetic information generated
remains a difficult task and reference assembly quality for
the cat presents additional variant detection challenges
[4]. The cat has a reference genome that was first assem-
bled with a 1.9X coverage genome sequence of an inbred
Abyssinian cat [5]. Additional sequencing of the same cat
to 14X and other cat breeds have allowed enhancement of
reference and the identification of common variation in
the cat genome [6]. However, the cat reference still has
flaws, such as gaps and unplaced sequences (not in
chromosomal regions) and these problems often hinder
the discovery of variants associated with phenotypes.
Genetic variant interpretation has been a massive chal-
lenge in genetic studies of any species. However, large-
scale human disease cohort sequencing projects and
even more important the development of databases con-
taining common variation and variants associated with
disease have eased this burden of following false positive
candidates. In dogs and cats, there have been variants
deposited into databases, such as dbSNP, but there is no
information on frequency, breed or health status of the
individuals from which variants were discovered. With-
out such data, future efforts to associate putatively dam-
aging variants with disease outcome are much less
efficient.
In this preliminary study of a feline colony pedigree,
we generated WGS data from three related cats within
the pedigree, which contains historical data from ~800
cats, in order to survey segregation of potential disease
variants and genetic diversity. We evaluated single nu-
cleotide variants (SNVs) and then compared to databases
containing information on genes associated with a dis-
ease. Additionally, we calculated runs of homozygosity
and inbreeding coefficients on each as a measure of gen-
etic health.
Methods
Animal descriptions
Three cats were selected for WGS that are part of a
pedigreed population maintained by Nestlé Purina as a
resource to study behavior preferences and nutritional
developments. The pedigree consists of Domestic short-
hair cats. We selected cats that were placed at an inter-
mediate position in the total pedigree structure. Also,
these cats were directly related allowing observation of
accumulation of damaging variants and if there is a de-
crease in genetic diversity. The health of the cat colony
is provided by a veterinary team with a proactive attitude
towards disease management. All cats have regular
health screening tests depending of their age risk and in-
dividual cases. Veterinary care is provided in the same
manner and principles than to any individually owned
house cat visiting a veterinary clinic, and all individual
clinical histories are recorded.
An example of an extended family within this pedigree
is depicted in Fig. 1, including the three WGS cats (Cat
I, Cat II, and Cat III). Cat I is an 8-year-old female that
is the dam of Cat II and has eight other offspring in the
pedigree. Cat II is a 6-year-old female that has about 40
half siblings on the pedigree. Also, Cat II is the dam of
Cat III and has two other offspring. Cat III is a 5-year-
old female with no offspring, but it has 15 half siblings
in the pedigree. All three cats were healthy based on an-
nual veterinarian physicals and no observed disease
symptoms during routine care. Samples of whole blood
were collected from each cat, by trained veterinary staff,
into an Acid Citrate Dextrose vacutainer tube. DNA was
isolated using the MagNA Pure 96 (Roche Diagnostics)
automated instrument according to the manufacturer’s
instructions.
Whole-genome sequencing and variant detection
Cats were sequenced on an Illumina HiSeq X10 instru-
ment with 350 to 550 bp PCR-free libraries to 150 bp
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read length. The sequence data for each cat were aligned
to the chromosomes of the domestic cat reference as-
sembly (Felis catus 8.0) using Speedseq [7]. Variants,
specifically SNVs and small indels (<10 bp), were called
using The Genome Analysis Toolkit (GATK) Haplotype-
Caller and GenotypeGVCFs [8]. Samtools flagstat [9]
and GATK DepthofCoverage were used to extract se-
quence alignment statistics. SNVs were then extracted
from all variants for further evaluation. All SNVs were
annotated using the Variant Annotation, Analysis and
Search Tool (VAAST 2) [10]. Next, SNVs predicted to
severely disrupt protein-coding genes, loss of function
(LoF) variants, shared between individuals or unique to
each were reported. In this study, we only considered
LoF variants with the most likely deleterious impact:
splice sites disruption, stop gain or loss, and frameshifts.
Variant validation and genotyping
To estimate our number of false SNVs detected, we se-
lected five variants to be validated by Sanger sequencing
in all three cats. We found two were homozygous, and
three were heterozygous genotypes. Additionally, two
closely related cats and five unrelated cats from the
pedigree were genotyped for the same variants to evalu-
ate expected genotypes. Sequences were amplified by
PCR using specific primers (Additional file 1: Table S1)
and Amplitaq Gold polymerase kit (Thermo Scientific)
according to the manufacturer’s protocol with the fol-
lowing modifications: AmpliTaq Gold concentration was
2.5 U/reaction, the forward and reverse primer concen-
trations were 0.4 μM (final concentration), and the de-
nature time was 30 s. PCR products were purified using
PureLink PCR purification kit (Thermo Scientific) fol-
lowing manufacturer’s protocol. After purification PCR
products were sent to GeneWiz (South Plainfield, NJ)
for Sanger sequencing. In addition, a set of 20 heterozy-
gous SNVs (Additional file 1: Table S2) genotyped on
the Illumina feline 63 K SNP BeadChip [4] from the
same three WGS cats were validated for equivalency of
SNVs calls.
Detection of variant impact
The databases Online Mendelian Inheritance in Man
(OMIM) [11], Online Mendelian Inheritance in Animals
(OMIA) [12] and the database of essential genes (DEG)
[13] were consulted for information on disease-causing
Pedigree based inbreeding coefficients:
Cat I:   0
Cat II:  0.003
Cat III: 0.064
SNPchip based inbreeding coefficients:
Cat I:   -0.508
Cat II:  -0.473
Cat III: -0.456
WGS based inbreeding coefficients:
Cat I:   -0.510
Cat II:  -0.496
Cat III: -0.474
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Fig. 1 Pedigree and inbreeding coefficients. The pedigree is showing close related individuals to the three WGS cats (red circles). Squares represent
males and circles represent females. Diagonal lines across symbols represent deceased cats. The asterisk indicates cats that have SNPchip data. On the
left are the inbreeding coefficients calculated based on pedigree, SNPchip and WGS data
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genes. We only considered genes in OMIM that were
associated with a phenotype and in OMIA, only genes
that were associated with phenotypes in cats. Also, genes
considered essential for mice were incorporated from
DEG in the analysis. All LoF variants in disease-causing
genes were manually evaluated with the Integrative
Genomics Viewer (IGV) [14], and SNV effect on each
gene was assessed by comparison of protein translation
to other mammals with NCBI blastp using default par-
ameter settings.
Known disease variants screening
Variants associated with disease in cats that have a com-
mercial DNA test available were screened in our three
cats by inspection of genotypes or presence of deletions
for the specific positions on sequence data. The list of
variants screened is in Additional file 1: Table S3 with
respective positions on cat reference version 8.0.
Inbreeding coefficient estimation
Pedigree-based inbreeding coefficient (IC) was calculated
using the Wright’s equation:
FX ¼
X 1
2
 n1þn2þ1
1þ FAð Þ
" #
Where Fx is the inbreeding coefficient of the cat in
question, FA is the inbreeding coefficient of the common
ancestor, n1 is the number of generations from the sire
to the common ancestor, and n2 is the number of gener-
ations from the dam to the common ancestor. We used
the known information about the pedigree (Fig. 1), how-
ever, there were unknown ancestors. IC was calculated
for Cat I based on three generations, Cat II based on five
generations and Cat III based on 6 generations.
Genotype data from the Illumina feline 63 K SNP
BeadChip (SNPchip) and WGS data based inbreeding
coefficients were calculated using PLINK v1.07 [15] –het
function. The SNPchip data was analyzed with 55,053
SNPs, while the WGS data was analyzed with 13,455,757
SNPs, both from autosomes only. Since we have
SNPchip data from 297 cats that are part of the pedi-
gree, we calculated IC using data for all the cats to com-
pare scores when calculating with only the three cats.
Runs of Homozygosity analysis
To calculate runs of homozygosity (RoH) for SNPchip
and WGS data we used PLINK v1.07 –homozyg func-
tion. For SNPchip data, we defined our RoH segments
as five or more consecutive homozygous SNVs per indi-
vidual. For WGS data we used a window size of 250 kb
since this approximate window size is roughly equivalent
to five homozygous SNVs on SNPchip data.
Results
Whole genome sequencing and variant validation
We generated WGS for each cat with an average range
of 27-32X coverage. The number of sequences that
properly mapped to Felis_catus-8.0 reference was be-
tween 92 and 97%, and duplicates were between 13 and
15% (Table 1). A total of 18,137,177 variants were identi-
fied in all three cats, 14,088,779 were SNVs and
4,048,398 were indels (Table 2). For this study we only
report putatively deleterious SNVs since indels are
known to have high rates of false positives [16].
We selected five SNVs (Additional file 1: Table S1)
for validation and genotyping in seven additional cats.
The two homozygous SNVs (chrE1:40,235,385 and
chrE1:40,235,189) were validated and also present on
the additional seven cats. The three heterozygous
SNVs were not validated, all cats were homozygous
for the reference allele. It was surprising that all three
heterozygous SNVs were false positives. Examination
of the regions containing the SNVs revealed that two
of those regions were located within sequences hom-
ologous to other sequences in the cat genome, which
may suggest that misalignment created the false posi-
tives. The convergence between SNPchip heterozygous
genotypes and WGS SNP showed 100% agreement
between calls, indicating our SNV calls are of high
confidence for further study.
Variant functional evaluation
Genes that harbored LoF variants were cross-referenced
with three databases containing information on pheno-
types associated with genes: OMIM, OMIA, and DEG.
Next, we manually checked variants in IGV and the pro-
tein translation similarity to other mammals. From the
genes associated with a phenotype, there was one homo-
zygous and two heterozygous shared LoFs between the
three cats, while there was one heterozygous unique
LoF. We first investigated the LoF variants that were
shared between the three cats in a homozygous and het-
erozygous state. Only one homozygous LoF was identi-
fied in a gene that matched OMIM and DEG databases;
it is an SNV that changes the splice site sequence on the
huntingtin-associated protein 1 (HAP1) gene (Fig. 2).
AHR and CTNNA2, which are genes in the DEG data-
base, both have a heterozygous LoF predicted to disrupt
Table 1 Whole-genome sequencing results summary
Cat I Cat II Cat III
Number of reads 639,766,569 575,104,522 552,808,448
Average coverage 32.13 27.86 27.79
Duplicates 15.52% 13.76% 14.78%
Mapped reads 97.19% 92.83% 96.70%
Properly paired 94.84% 89.99% 93.96%
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Table 2 The number of variants identified for each cat, including SNPs and Indels. Variants are divided by annotation categories
Total Non-synonymous Frameshift Splice site Stop gain/loss
Cat I
all 13,791,282 28,984 2394 656 650
homozygous 4,722,225 8502 1106 237 179
unique 1,947,067 4256 290 104 110
Cat II
all 13,663,921 28,961 2414 636 627
homozygous 4,808,547 8605 1115 255 170
unique 1,142,035 2399 244 70 58
Cat III
all 13,635,215 28,467 2380 632 622
homozygous 4,882,667 8869 1115 230 189
unique 1,708,602 3399 317 92 79
Shared
all 9,196,149 19,377 1730 434 407
homozygous 2,597,948 4947 898 131 108
Fig. 2 Homozygous LoF on HAP1 gene. The variant in HAP1 gene is homozygous on all three cats and it changes the splice donor sequence
from GT to GG. This variant has been previously identified in other cats and has been deposited in dbSNP
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splice sites. Furthermore, we investigated unique LoFs
homozygous and heterozygous in each cat and no
unique homozygous LoFs in genes that matched the da-
tabases were found. There was only one heterozygous
LoF in Cat III that creates a stop five amino acids before
the end of the immunoglobulin mu binding protein 2
(IGHMBP2) protein. The positions and types of LoFs are
described in Additional file 1: Table S4. Overall, we ob-
served a high number of false positive LoFs at ~42%,
based on the variants manually inspected, that we attri-
bute to inaccurate gene models.
Screening for known cat disease variants
To ascertain if our screening would find known disease
alleles, even though our cats were deemed healthy by
veterinarian exams, we screened our three cats for vari-
ants that match these causative alleles. Each has accom-
panying commercial DNA tests that could confirm their
putative disease carrier status in our pedigree. Some of
these diseases are breed specific while all cats that are
part of this pedigree are mixed breed so their frequency
would be expected to be rare and in some cases may not
present disease phenotype in a mixed genetic back-
ground. The diseases screened for relevant variants were:
Gangliosidosis 1 [17], Gangliosidosis 2 [18], Cardiomy-
opathy [19, 20], Hypokalemia [21], Progressive retinal at-
rophy [22], Polycystic kidney [3], and Spinal muscular
atrophy [23]. The occurrences of some of these diseases
in our pedigree lead us to screen these variants even
though the three cats selected are healthy. We found no
instances matching disease variants.
Inbreeding coefficients
We calculated IC to gauge genetic diversity using avail-
able pedigree relationships, SNPchip and WGS data for
all three cats (Fig. 1). New male cats were frequently in-
troduced to the pedigree to keep genetic diversity high
but in most cases, these sires lack ancestry information
as shown in Fig. 1. Pedigree based IC was calculated on
available information on ancestors using the Wright’s
equation. Cat III had the highest pedigree based IC,
most likely due to this cat having more pedigree infor-
mation than the others. IC from SNPchip and WGS data
were calculated on the observed versus expected number
of homozygous genotypes. SNPchip and WGS based ICs
were equivalent, as is expected since both were calcu-
lated by the same method. The IC was remarkably low
in all three analyses. Since there is missing ancestry in-
formation for some of the cats, IC calculated based on
SNPchip and WGS data are more reliable than the
pedigree-based. However, IC calculated by PLINK is
more accurate when calculated with larger sample size.
When IC was calculated with 297 individuals the scores
were higher (Aditional file 1: Table S5) while still
negative indicating high rate of heterozygosity (CatI:
−0.508, −0.057; CatII: −0.473, −0.034; CatIII: −0.456,
−0.022; IC calculated with three cats and IC calculated
with 297 cats respectively).
Detection of RoH in SNPchip and WGS data
The estimation of the level of homozygosity in our pedi-
gree associated cats was carried out with SNPchip and
WGS data using different window sizes, five consecutive
homozygous SNPs and 250 kb, respectively. WGS ana-
lysis was done in window size instead of a number of
consecutive homozygous SNPs, because the distances
between SNPs are on average less than 500 bp apart
compared to SNPchip markers that are on average 50 kb
apart. SNPchip data analysis detected 20–27 RoH seg-
ments (Additional file 1: Table S6) while WGS data ana-
lysis detected 24–57 RoH segments (Additional file 1:
Table S7). The higher number of RoH identified by
WGS data is expected given the higher resolution of de-
tected variants. Comparison of the analysis of the two
datasets shows that there was considerable overlap for
both, but the length of the RoH was much higher for
SNPchip data (average 6344 kb SNPchip, average 324 kb
WGS). RoH segments identified by SNPchip data were
frequently broken into smaller RoH segments identified
by WGS when there was overlap. Some of the segments
are fully or partially shared between cats for each data
set. Cat III has the higher number of RoH for both data
sets (27 for SNPchip and 57 for WGS) compared to the
other two cats. The low numbers of RoH segments iden-
tified corresponds to the low IC observed for theses cats
calculated with SNPchip and WGS data.
Discussion
Genetic diversity plays an important role in maintaining
a healthy pedigree. While the success of a genetically di-
verse pedigree relies on an effective breeding program,
mating decisions with inadequate genetic information
could have unintended consequences in future genera-
tions. The traditional process of selecting individuals for
breeding involves calculations of inbreeding prior to
mating in order to optimize hybrid vigor as well as con-
sideration of traits and symptoms when they became ap-
parent in the sire or dam and offspring. Unlike the
mating decisions made in food-producing animals, de-
termined largely by the need to improve phenotypes of
economic interest, health is the major priority in man-
aging companion animal pedigrees. The identification of
genetic variants within genes implicated in clinically
relevant phenotypes provides a new means to avoid the
spread of unintended alleles with harmful outcomes be-
fore breeding. Already veterinarians are attempting to
utilize genetic information as a diagnostic and clinical
management aid. However, limited validation of
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numerous putative alleles of clinical significance has
hampered their abilities. In a well-maintained pedigree,
undesirable recessive phenotypes can be avoided by se-
lective breeding to circumvent the production of homo-
zygous individuals, thus preventing propagation of
individuals with potentially adverse health conditions.
We contend that the use of WGS data to assess sire and
dam mutational profiles and to determine genetic diver-
sity can help to improve animal health and in maintain-
ing offspring genome diversity in the pedigree.
In our limited study of pedigree associated cats, we
first analyzed potential clinical relevant variants. Several
variants have been associated with diseases in cats [1]
and some have commercially available genetic tests for
breeders to screen their animals. Nonetheless, not all
tests are applicable breed wide, for example, the Gang-
liosidosis 2 HEXB variant [18] is specific for the Burmese
breed. The mixed breed cats in our pedigree do show
occurrences of a few of these diseases in the pedigree,
such as Polycystic kidney disease (PKD). PKD was esti-
mated to have a prevalence of 30–38% worldwide in
Persian and closely related cat breeds [24–26]. There-
fore, there was a possibility that the cats in our pedigree
carry one or more of the PKD disease alleles. However,
screening for all known disease variants revealed that
our cats do not carry any of these causative alleles, but
continued surveillance is needed for the appearance of
new disease causative alleles.
The tremendous expansion of variant knowledge
among human studies can reveal shared genic events, at
least within the same gene, that may be of clinical rele-
vance in veterinarian care. In this report, we find several
cases of shared variants that could lead to future health
consequences but most often is undetected phenotypic-
ally. Shared among the three cats we have identified a
homozygous splice-site SNV in the gene HAP1. This
SNV has been identified previously in other cats accord-
ing to dbSNP, rs784247714, and it was also identified in
the additional seven cats we genotyped from the pedi-
gree. The HAP1 protein interacts with the huntingtin
protein [27], which is associated with Huntington dis-
ease [28]. However, HAP1 itself has not been directly
linked to Huntington disease. Chan et al. [29] have
shown that Hap1 knockout mice exhibit strikingly de-
pressed feeding behavior and are unable to gain body
weight after birth. The mice often die after day 2–3, but
the ones that survive displayed growth retardation with
apparent normal brain and behavioral development sug-
gesting an effect only in early postnatal feeding behavior
[30]. In our three cats, no similar abnormal feeding be-
havior has been observed, which may suggest that this
mutation does not affect the protein function. Alterna-
tively, the creation of a protein isoform that skips one
exon is fully functional.
We identified two heterozygous LoF variants shared by
the three cats that matched AHR and CTNNA2, which are
considered essential genes for survival in mice according to
DEG. The aryl hydrocarbon receptor plays important roles
in the developmental remodeling of vascular architecture
in the liver [31], regulates the toxicity of halogenated di-
oxins [32] and controls the adaptive up-regulation of xeno-
biotic metabolizing enzymes in response to polycyclic
aromatic hydrocarbons [33]. In Ahr-null mice disruption of
AHR signaling pathway causes fetal necrosis and conse-
quent liver deformation which persists through adulthood
[34]. The CTNNA2 protein links the classical cadherins to
the neuronal cytoskeleton and is expressed only in the cen-
tral nervous system in mice [35]. Mice lacking part of the
CTNNA2 protein are ataxic and show abnormal lobulation
of the cerebellum and cerebellar hypoplasia [36]. These
phenotypes haven’t been observed in the pedigree so far,
however, our discoveries highlight how pedigree breeding
management would provide a means to avoid the propaga-
tion of these alleles in subsequent generations.
Additionally, we explored unique LoFs for each cat. We
identified a heterozygous stop gained SNV on IGHMBP2
gene unique to Cat III. Mutations in this gene are reported
to cause distal spinal muscle atrophy type 1 [37] and
Charcot-Marie-Tooth disease type 2 [38]. The stop gained,
found in our cat, was 5 amino acids before the end of the
protein, it is most likely that this SNV do not affect protein
function. Given its haploid state in Cat III and no observed
health abnormalities this variant is not considered to be a
risk for disease development, therefore not affecting the
decision to include this cat in the breeding pool. The effect
of variants in gene function is not easily predicted. Despite
the tools that classify variants as benign or damaging, it is
of substantial advantage to having access to a common var-
iants database, where information on health status and
breed are recorded for each variant identified. In this ex-
ample, we would greatly benefit from that information to
determine if this SNV is benign or damaging. The need for
a robust repository for variants in cats is critical for re-
search in disease or trait variant discovery. In humans,
great efforts have been made to create databases recoding
variant information with different levels of evidence impli-
cating variants in disease risk or causation, such as Clin-
Var. Also, guidelines for associating variants to disease
have been described to avoid a proliferation of false posi-
tive findings [39].
To access inbreeding status of the three cats, IC was
calculated based in three data sets: pedigree information,
SNPchip, and WGS data. Pedigree information was lim-
ited for part of the ancestors because cats are frequently
introduced to the pedigree. ICs based on pedigree were
higher than the ones calculated with SNPchip and WGS
data. SNPchip and WGS ICs were interchangeable for
each of the cats; the ICs were negative indicating a high
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rate of heterozygosity relative to their reference popula-
tion. However, we observed that larger sample sizes are
recommended for higher accuracy when calculating IC
with genetic data. Our results for a small sampling of
the pedigree reveal efforts to maintain diversity is suc-
cessful thus far. The analysis of runs of homozygosity
(RoH) with SNPchip and WGS data has shown that
SNPchip analysis overestimates length and underesti-
mates the number of RoH. WGS has a better resolution
for this type of analysis because it genotypes every position
while SNPchip analysis doesn’t consider heterozygosity
between markers and markers are in average 50 kb apart.
The number of RoH segments identified for both datasets
are in agreement with the low ICs observed.
Conclusions
In summary, we describe the assessment and possible
use of genomic information of three cats from a large
pedigree. We are cognizant of the limitations that
three cat genomes could provide to the management
of large pedigrees, nonetheless, our genome variant
data has enabled us to identify possible disease caus-
ing variants, plan more cost-effective screening assays
using this data and obtain an estimate of pedigree
genetic diversity. The decision on inclusion and ex-
clusion of cats in the breeding pool based on genetic
variants must be carefully considered. First and fore-
most, variants that are known to cause disease should
be regarded as most important during breeding man-
agement. The variants predicted to be damaging
should be complemented by clinical observations of
animals to conclude that they impact health. Since
genetic diversity is as crucial as avoiding the spread-
ing of disease-causing variants, it is necessary to bal-
ance the breeding pool via mating selections that
safeguard genetic diversity while minimizing the accu-
mulation of damaging variants. Once disease variants
are discovered, they can be cost effectively screened
as part of marker panels, much akin to human clin-
ical disease screening protocols, to better manage
pedigree health. The expectation is genome data stra-
tegically collected can be a powerful tool to improve
animal health.
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and PCR annealing temperatures; Table S2. Heterozygous SNPs selected
from SNPchip data for cross validation; Table S3. Variants associated with
diseases in cats with a commercial DNA test available; Table S4. LoF
variants identified in genes associated with disease; Table S5. Inbreeding
coefficient calculated with SNPchip data of only 3 cats and with SNPchip
data of 297 cats ; Table S6. RoH identified with SNPchip data on the three
cats; Table S7. RoH identified with WGS data on the three cats. The last
column has the overlap with SNPchip RoH number. (DOCX 42 kb)
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